Guardant Health Inc (NAS:GH)
$ 23.39 -0.21 (-0.89%) Market Cap: 2.88 Bil Enterprise Value: 3.20 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at Leerink Partners Global Healthcare Conference Transcript

Feb 28, 2019 / 02:00PM GMT
Release Date Price: $66.64 (+19.71%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools, Diagnostics, and Senior Research Analyst

We'll go ahead and get started. With me, I have the pleasure of having Helmy. We -- I think you have a couple of slides and then I'll have a couple of questions after that so let's maybe just start with the couple of slides then we'll go through the questions.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Yes. Thank you for invitation to the conference. Here is our safe harbor statement. So the mission of Guardant Health is to conquer cancer with data. Data really being the operative word. We believe that health care is ultimately very data starved and that being able to provide tools that can provide access to diseases underlying molecular information is going to be critical to really counteracting disease and intervening as early as possible.

There's been a lot of progress in oncology, precision medicine and precision oncology. But it has mostly been confined to the metastatic setting and so the idea is if we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot